STAT3 and cancer: It's reported that Cu-I exerts antitumorigenic activity by a ROS-mediated mechanism without inhibiting STAT3,18, 23 suggesting targeting the redox homeostasis may be an alternative mechanism of action for Cu-I in killing the cancer cells.